Applied Biosystems last week launched its TaqMan microRNA assays, thrusting the firm into an emerging niche market that has yet to establish a dominant player.

ABI is banking on its broad market reach, reputation of TaqMan, and currently installed instrument base to establish a presence in the microRNA market. In addition, the firm should be able to take advantage of its collaboration with noted genetics and microRNA researcher Victor Ambros of Dartmouth University to raise its profile among researchers in the field.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.